333 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
301 | 10648652 | Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease. | 2000 Feb | 2 |
302 | 10976649 | Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. | 2000 Sep | 2 |
303 | 10984725 | Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. | 2000 Sep | 1 |
304 | 10994012 | Treatment of REM sleep behavior disorder with donepezil: a report of three cases. | 2000 Sep 26 | 1 |
305 | 11068139 | Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain. | 2000 | 8 |
306 | 11078030 | The new cholinesterase inhibitors for Alzheimer's disease, Part 1: their similarities are different. | 2000 Oct | 1 |
307 | 11198060 | Adverse effects associated with the use of donepezil in general practice in England. | 2000 | 1 |
308 | 11256231 | Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. | 2000 Oct | 5 |
309 | 11343620 | Management of cognition and function: new results from the clinical trials programme of Aricept(R) (donepezil HCl). | 2000 Jul | 1 |
310 | 22033801 | A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease. | 2000 Jun | 2 |
311 | 9876215 | Clinical profile of donepezil in the treatment of Alzheimer's disease. | 1999 | 2 |
312 | 9924498 | What's new in Alzheimer's disease treatment? Reasons for optimism about future pharmacologic options. | 1999 Jan | 1 |
313 | 10332937 | Clinical benefits of a new piperidine-class AChE inhibitor. | 1999 Apr | 1 |
314 | 10363493 | [Treatment of Alzheimer's disease: acetylcholinesterase inhibitors]. | 1999 Apr | 2 |
315 | 10447153 | Defining meaningful change in Alzheimer's disease trials: the donepezil experience. | 1999 Spring | 1 |
316 | 10549687 | Donepezil for psychotropic-induced memory loss. | 1999 Oct | 1 |
317 | 10622674 | Assessing the societal impact of acetylcholinesterase inhibitor therapies. | 1999 Nov | 1 |
318 | 11249555 | The pharmacology of donepezil: a new treatment of Alzheimer's disease. | 1999 Nov | 3 |
319 | 9475825 | Donepezil use in Alzheimer disease. | 1998 Jan | 1 |
320 | 9771828 | New cholinergic therapies: treatment tools for the psychiatrist. | 1998 | 1 |
321 | 9839758 | Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses. | 1998 Nov | 6 |
322 | 9839759 | Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses. | 1998 Nov | 4 |
323 | 9853200 | Perspectives in the management of Alzheimer's disease: clinical profile of donepezil. | 1998 | 2 |
324 | 15616667 | Alzheimer's disease therapy - an update. | 1998 May | 1 |
325 | 9062656 | Abnormalities of acetylcholinesterase in Alzheimer's disease with special reference to effect of acetylcholinesterase inhibitor. | 1997 Feb | 1 |
326 | 9108896 | Donepezil. | 1997 Mar | 2 |
327 | 9228650 | Effects of NIK-247 on cholinesterase and scopolamine-induced amnesia. | 1997 May | 2 |
328 | 9428950 | Donepezil: an anticholinesterase inhibitor for Alzheimer's disease. | 1997 Dec 15 | 3 |
329 | 9548205 | Therapeutic advances: donepezil for the treatment of Alzheimer's disease. | 1997 Aug | 1 |
330 | 15989517 | Donepezil (E2020): a new acetylcholinesterase inhibitor. Review of its pharmacology, pharmacokinetics, and utility in the treatment of Alzheimer's disease. | 1997 Oct | 4 |
331 | 8915035 | The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. | 1996 Nov-Dec | 1 |
332 | 8535413 | Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020). | 1995 Aug | 1 |
333 | 7738604 | Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program. | 1994 Dec | 3 |